These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15074308)

  • 1. Can syndecan-1 become a prognostic factor in solid tumors?
    Oguri K; Okayama M
    J Gastroenterol; 2004; 39(2):197-9. PubMed ID: 15074308
    [No Abstract]   [Full Text] [Related]  

  • 2. [Syndecan-1 (CD138): an immunohistochemical marker of plasma cell tumors].
    Fakan F; Boudová L; Hejda C
    Cesk Patol; 2002 Jan; 38(1):33-6. PubMed ID: 11933459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syndecan-1: a new prognostic marker in laryngeal cancer.
    Pulkkinen JO; Penttinen M; Jalkanen M; Klemi P; Grénman R
    Acta Otolaryngol; 1997 Mar; 117(2):312-5. PubMed ID: 9105473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between syndecan-1 expression and clinical outcome in squamous cell carcinoma of the head and neck.
    Inki P; Joensuu H; Grénman R; Klemi P; Jalkanen M
    Br J Cancer; 1994 Aug; 70(2):319-23. PubMed ID: 8054282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SYNDECAN-1 (CD138) expression in human non-Hodgkin's lymphomas.
    Sutcliffe M; Oscier D; Wright DH
    Br J Haematol; 2000 Jul; 110(1):239-40. PubMed ID: 10931010
    [No Abstract]   [Full Text] [Related]  

  • 6. Syndecan-1 in multiple myeloma: relationship to conventional prognostic factors.
    Aref S; Goda T; El-Sherbiny M
    Hematology; 2003 Aug; 8(4):221-8. PubMed ID: 12911939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syndecan-1 expression--a novel prognostic marker in pancreatic cancer.
    Juuti A; Nordling S; Lundin J; Louhimo J; Haglund C
    Oncology; 2005; 68(2-3):97-106. PubMed ID: 15886501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of syndecan-1 expression in breast cancer.
    Leivonen M; Lundin J; Nordling S; von Boguslawski K; Haglund C
    Oncology; 2004; 67(1):11-8. PubMed ID: 15459490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prognostic value of syndecan-1 in gastric cancer.
    Wiksten JP; Lundin J; Nordling S; Kokkola A; Haglund C
    Anticancer Res; 2000; 20(6D):4905-7. PubMed ID: 11326638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syndecan-1 expression is decreased with increasing aggressiveness of basal cell carcinoma.
    Bayer-Garner IB; Dilday B; Sanderson RD; Smoller BR
    Am J Dermatopathol; 2000 Apr; 22(2):119-22. PubMed ID: 10770430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The expression of cell adhesion molecule Syndecan-1 and E-candherin in laryngeal cancer].
    Li Y; Yang C
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 Dec; 17(12):736-8. PubMed ID: 15017723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syndecan-1 expression has prognostic significance in head and neck carcinoma.
    Anttonen A; Kajanti M; Heikkilä P; Jalkanen M; Joensuu H
    Br J Cancer; 1999 Feb; 79(3-4):558-64. PubMed ID: 10027330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical study of syndecan-1 down-regulation and the expression of p53 protein or Ki-67 antigen in oral leukoplakia with or without epithelial dysplasia.
    Kurokawa H; Matsumoto S; Murata T; Yamashita Y; Tomoyose T; Zhang M; Fukuyama H; Takahashi T
    J Oral Pathol Med; 2003 Oct; 32(9):513-21. PubMed ID: 12969225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of BCL-6 protein and CD138/syndecan-1 as B-cell markers in Hodgkin's disease.
    Carbone A; Gloghini A; Gaidano G
    Int J Biol Markers; 1999; 14(3):144-8. PubMed ID: 10569135
    [No Abstract]   [Full Text] [Related]  

  • 15. Association of syndecan-1 with tumor grade and histology in primary invasive cervical carcinoma.
    Rintala M; Inki P; Klemi P; Jalkanen M; Grénman S
    Gynecol Oncol; 1999 Dec; 75(3):372-8. PubMed ID: 10600292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syndecan-1 expression in malignant mesothelioma: correlation with cell differentiation, WT1 expression, and clinical outcome.
    Kumar-Singh S; Jacobs W; Dhaene K; Weyn B; Bogers J; Weyler J; Van Marck E
    J Pathol; 1998 Nov; 186(3):300-5. PubMed ID: 10211120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of syndecans 1-4 within the anterior segment of the human eye: expression of a variant syndecan-3 and matrix-associated syndecan-2.
    Filla MS; David G; Weinreb RN; Kaufman PL; Peters DM
    Exp Eye Res; 2004 Jul; 79(1):61-74. PubMed ID: 15183101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syndecans-1 and -4 are induced during wound repair of neonatal but not fetal skin.
    Gallo R; Kim C; Kokenyesi R; Adzick NS; Bernfield M
    J Invest Dermatol; 1996 Nov; 107(5):676-83. PubMed ID: 8875948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of fibroblast growth factor receptor-1, -2, and -3 and syndecan-1, -2, and -4 in neonatal rat mandibular condyle and calvaria during osteogenic differentiation in vitro.
    Molténi A; Modrowski D; Hott M; Marie PJ
    Bone; 1999 Apr; 24(4):337-47. PubMed ID: 10221546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of induction chemotherapy on changes of laminin and syndecan expression in oral squamous cell carcinomas: a prospective, randomized, clinicopathologic and immunohistochemical study.
    Németh Z; Szigeti K; Máthé M; Szabó G; Velich N; Suba Z
    J Craniofac Surg; 2005 Mar; 16(2):205-12. PubMed ID: 15750416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.